GSTT1 Copy Number Gain and ZNF Overexpression Are Predictors of Poor Response to Imatinib in Gastrointestinal Stromal Tumors

GSTT1 Copy Number Gain and ZNF Overexpression Are Predictors of Poor Response to Imatinib in Gastrointestinal Stromal Tumors

Oncogenic mutations in gastrointestinal stromal tumors (GISTs) predict prognosis and therapeutic responses to imatinib. In wild-type GISTs, the tumor-initiating events are still unknown, and wild-type GISTs are resistant to imatinib therapy. We performed an association study between copy number alte...

Full description

Bibliographic Details
Main Authors: Lee, Eui Jin, Kang, Guhyun, Kang, Shin Woo, Jang, Kee-Taek, Lee, Jeeyun, Park, Joon Oh, Park, Cheol Keun, Sohn, Tae Sung, Kim, Sung, Kim, Kyoung-Mee
Format: Online
Language:English
Published: Public Library of Science 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790698/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790698/

Similar Items